Nanovision (Biotechnology) Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 35
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $7M
Latest Deal Amount

Nanovision (Biotechnology) General Information

Description

Provider of degenerative retinal disorder treatment intended to restore sight. The company's treatment works with implanted nanowire retinal prosthesis that converts incident light into electric fields thereby stimulating inner retinal neurons, enabling patients with degenerative retinal disorders to enjoy life without the fear of blindness.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Other Healthcare Services
Primary Office
  • 9171 Towne Centre Drive
  • Suite 250
  • San Diego, CA 92122
  • United States
+1 (858) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanovision (Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 01-Mar-2016 $7M 000.00 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 10-Apr-2012 00.00 00.00 000.00 Completed Startup
To view Nanovision (Biotechnology)’s complete valuation and funding history, request access »

Nanovision (Biotechnology) Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 0,000,000 00.000000 00.0 00.00 00.00 00 00.00 00.000
To view Nanovision (Biotechnology)’s complete cap table history, request access »

Nanovision (Biotechnology) Executive Team (7)

Name Title Board Seat Contact Info
Scott Thorogood Co-Founder, Chief Executive Officer & Chairman
Larry Murrill Chief Financial Officer
Hiren Thacker Ph.D Chief Technology Officer
Sue Bauchner Director, Engineering
William Freeman MD Co-Founder, Medical Consultant & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

Nanovision (Biotechnology) Board Members (3)

Name Representing Role Since
Paul Citron Ph.D Nanovision (Biotechnology) Board Observer 000 0000
Scott Thorogood Nanovision (Biotechnology) Co-Founder, Chief Executive Officer & Chairman 000 0000
William Freeman MD Nanovision (Biotechnology) Co-Founder, Medical Consultant & Board Member 000 0000
To view Nanovision (Biotechnology)’s complete board members history, request access »

Nanovision (Biotechnology) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial